Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early

C M Dalton1, P A Brex, R Jenkins

  • 1NMR Research Unit, Institute of Neurology, London, UK.

Abstract

Insights

Brain atrophy and lesion load are linked to early multiple sclerosis (MS) development in patients with clinically isolated syndromes (CIS). MRI measures can help monitor early MS progression.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimmunology

Background:

  • Clinically isolated syndromes (CIS) can precede multiple sclerosis (MS).
  • Brain lesion load on MRI predicts MS development in CIS patients.
  • Cerebral atrophy in early MS is not well understood regarding onset and relation to lesion load or clinical outcomes.

Purpose of the Study:

  • Investigate ventricular enlargement over one year in CIS patients.
  • Explore the relationship between ventricular enlargement, MRI lesion load, and clinical outcomes in early MS.

Main Methods:

  • A cohort of 55 CIS patients were recruited and imaged using MRI within three months of symptom onset and again after one year.
  • A semi-automated thresholding technique (MIDAS) was used to measure ventricular volume from MRI scans.
  • Patients were assessed for the development of clinically definite MS and fulfillment of McDonald MRI criteria.

Main Results:

  • 16 of 40 patients with abnormal baseline T2 scans developed clinical MS within one year.
  • Significant ventricular enlargement occurred in 27 of 55 patients meeting MS criteria, with a median increase of 0.3 cm³.
  • Significant ventricular volume increase was observed in 18 of 55 patients who developed clinical MS, with a median increase of 0.5 cm³.
  • Modest correlations were found between baseline lesion measures and subsequent ventricular enlargement.

Conclusions:

  • Both MRI-detected lesions and cerebral atrophy are associated with early relapse and diagnosis of clinical MS.
  • While MS lesions contribute to atrophy, other mechanisms may also drive its development.
  • MRI measures play a complementary role in monitoring MS progression, even in its earliest stages.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...